Danellys Borroto

Appearances

IMPACT OF RIFAXIMIN USE DURING THE 30-DAY POST-DISCHARGE PERIOD FOLLOWING AN OVERT HEPATIC ENCEPHALOPATHY HOSPITALIZATION ON HEALTHCARE UTILIZATION AND COSTS
Date
May 8, 2023
BACKGROUND AND AIMS: Screening tools are needed for early detection of NAFLD-fibrosis. We aimed to identify risk factors for NAFLD-fibrosis in the multiethnic population of the U.S. and thus accelerate development of equitable screening tools…
Presenter
Arun Jesudian
Speakers
Patrick Gagnon-Sanschagrin
Zeev Heimanson
Rebecca Bungay
Jingyi Chen
Annie Guérin
Ankur Dashputre
Brock Bumpass
Danellys Borroto
George Joseph